Polarity Plus
- Manufacturer
- Deseret Biologicals, Inc. | Apotheca Company
- Effective date
- 2022-11-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:48:37
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Aqua solis 30C, 200C, 1M, 10M, Argentum metallicum 1M, 10M, Aurum metallicum 1M, 10M, Cuprum metallicum 1M, 10M, Lapis albus 1M, 10M, Manganum metallicum 1M, 10M, Vanadium metallicum 1M, 10M, Viscum album 1M, 10M, Zincum metallicum 1M, 10M.
OTC - PURPOSE SECTION
INDICATIONS: For the correction of symptoms related to polarity dysfunction including vertigo, tingling sensation, poor memory, light sensitivity, nosebleeds, mood swings, jet lag, obsessive/compulsive behavior, and learning difficulties.
WARNINGS SECTION
WARNINGS: Keep out of reach of children. In case of overdose, contact physician or Poison Control Center right away.
If pregnant or breast feeding, seek advice of a health professional before use.
Tamper seal: "Sealed for Your Protection." Do not use if seal is broken or missing.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: 1-10 drops under the tongue 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Demineralized water, 25% Ethanol.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, contact physician or Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS: For the correction of symptoms related to polarity dysfunction including vertigo, tingling sensation, poor memory, light sensitivity, nosebleeds, mood swings, jet lag, obsessive/compulsive behavior, and learning difficulties.
OTC - QUESTIONS SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DESBIO
NDC 43742-0055-1
HOMEOPATHIC
POLARITY PLUS
1 FL OZ (30 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43742-0055-1 | 2022-11-10 | C162847 | 48780-1 | 9d75b9d0-b491-f424-e053-dadaa90a57ce | Drug Facts |
| 43742-0055-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b491-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM HEXAFLUOROSILICATE | ACTIVE INGREDIENT | 2NVP93XVQ3 | 2 | |
| COPPER | ACTIVE INGREDIENT | 789U1901C5 | 2 | |
| GOLD | ACTIVE INGREDIENT | 79Y1949PYO | 2 | |
| MANGANESE | ACTIVE INGREDIENT | 42Z2K6ZL8P | 2 | |
| SILVER | ACTIVE INGREDIENT | 3M4G523W1G | 2 | |
| VANADIUM | ACTIVE INGREDIENT | 00J9J9XKDE | 2 | |
| VISCUM ALBUM FRUITING TOP | ACTIVE INGREDIENT | BK9092J5MP | 2 | |
| WATER | ACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| ZINC | ACTIVE INGREDIENT | J41CSQ7QDS | 2 | |
| CALCIUM HEXAFLUOROSILICATE | ACTIVE MOIETY | 2NVP93XVQ3 | 2 | |
| COPPER | ACTIVE MOIETY | 789U1901C5 | 2 | |
| GOLD | ACTIVE MOIETY | 79Y1949PYO | 2 | |
| MANGANESE | ACTIVE MOIETY | 42Z2K6ZL8P | 2 | |
| SILVER | ACTIVE MOIETY | 3M4G523W1G | 2 | |
| VANADIUM | ACTIVE MOIETY | 00J9J9XKDE | 2 | |
| VISCUM ALBUM FRUITING TOP | ACTIVE MOIETY | BK9092J5MP | 2 | |
| WATER | ACTIVE MOIETY | 059QF0KO0R | 2 | |
| ZINC | ACTIVE MOIETY | J41CSQ7QDS | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 |
Products#
Every source-derived product name is available through these pages.
- Polarity Plus
- Aqua solis, Argentum metallicum, Aurum metallicim, Cuprum metallicum, Lapis albus, Manganum metallicum, Vanadium metallicum, Viscum album, Zincum metallicum
- WATER
- SILVER
- GOLD
- COPPER
- CALCIUM HEXAFLUOROSILICATE
- MANGANESE
- VANADIUM
- VISCUM ALBUM FRUITING TOP
- ZINC
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43742-0055 | 43742-0055-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | ACTIB |
| SILVER | 3M4G523W1G | ACTIB |
| GOLD | 79Y1949PYO | ACTIB |
| COPPER | 789U1901C5 | ACTIB |
| CALCIUM HEXAFLUOROSILICATE | 2NVP93XVQ3 | ACTIB |
| MANGANESE | 42Z2K6ZL8P | ACTIB |
| VANADIUM | 00J9J9XKDE | ACTIB |
| VISCUM ALBUM FRUITING TOP | BK9092J5MP | ACTIB |
| ZINC | J41CSQ7QDS | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c2e81ff8-b2f8-4b69-bd16-5b8b2d18c2d8 | e9d5d8f8-03f9-42fc-b1b9-ee1152f86125 | 2022-11-10 | Warnings | c2e81ff8-b2f8-4b69-bd16-5b8b2d18c2d8 e9d5d8f8-03f9-42fc-b1b9-ee1152f86125 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
